Back to Search Start Over

Patterns of Radiotherapy Practice for Patients With Cervical Cancer in Japan, 2003–2005: Changing Trends in the Pattern of Care Process

Authors :
Tomita, Natsuo
Toita, Takafumi
Kodaira, Takeshi
Shinoda, Atsunori
Uno, Takashi
Numasaki, Hodaka
Teshima, Teruki
Mitsumori, Michihide
Source :
International Journal of Radiation Oncology, Biology, Physics. Aug2012, Vol. 83 Issue 5, p1506-1513. 8p.
Publication Year :
2012

Abstract

Purpose: The patterns of care study (PCS) of radiotherapy for cervical cancer in Japan over the last 10 years was reviewed. Methods and Materials: The Japanese PCS working group analyzed data from 1,200 patients (1995–1997, 591 patients; 1999–2001, 324 patients; 2003–2005, 285 patients) with cervical cancer treated with definitive radiotherapy in Japan. Results: Patients in the 2001–2003 survey were significantly younger than those in the 1999–2001 study (p < 0.0001). Histology, performance status, and International Federation of Gynecology and Obstetrics stage were not significantly different among the three survey periods. Use of combinations of chemotherapy has increased significantly during those periods (1995–1997, 24%; 1999–2001, 33%; 2003–2005, 54%; p < 0.0001). The ratio of patients receiving concurrent chemotherapy has also dramatically increased (1995–1997, 20%; 1999–2001, 54%; 2003–2005, 83%; p < 0.0001). As for external beam radiotherapy (EBRT), the application rate of four-field portals has greatly increased over the three survey periods (1995–1997, 2%; 1999–2001, 7%; 2003–2005, 21%; p < 0.0001). In addition, the use of an appropriate beam energy for EBRT has shown an increase (1995–1997, 67%; 1999–2001, 74%; 2003–2005, 81%; p = 0.064). As for intracavitary brachytherapy (ICBT), an iridium source has become increasingly popular (1995–1997, 27%; 1999–2001, 42%; 2003–2005, 84%; p < 0.0001). Among the three surveys, the ratio of patients receiving ICBT (1995–1997, 77%; 1999–2001, 82%; 2003–2005, 78%) has not changed. Although follow-up was inadequate in each survey, no significant survival differences were observed (p = 0.36), and rates of late Grade 3 or higher toxicity were significantly different (p = 0.016). Conclusions: The Japanese PCS has monitored consistent improvements over the past 10 years in the application of chemotherapy, timing of chemotherapy, and EBRT methods. However, there is still room for improvement, especially in the clinical practice of ICBT. [Copyright &y& Elsevier]

Details

Language :
English
ISSN :
03603016
Volume :
83
Issue :
5
Database :
Academic Search Index
Journal :
International Journal of Radiation Oncology, Biology, Physics
Publication Type :
Academic Journal
Accession number :
85153302
Full Text :
https://doi.org/10.1016/j.ijrobp.2011.10.013